Compounds > lonidamine
Page last updated: 2024-08-23

lonidamine and Cancer, Radiation-Induced

lonidamine has been researched along with Cancer, Radiation-Induced in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hahn, GM; Ning, SC2

Other Studies

2 other study(ies) available for lonidamine and Cancer, Radiation-Induced

ArticleYear
Combination therapy: lonidamine, hyperthermia, and chemotherapy against the RIF-1 tumor in vivo.
    Cancer research, 1991, Nov-01, Volume: 51, Issue:21

    Topics: Animals; Antineoplastic Agents; Bleomycin; Carmustine; Combined Modality Therapy; Fibrosarcoma; Fluorouracil; Hyperthermia, Induced; Indazoles; Male; Mice; Mice, Inbred C3H; Neoplasms, Radiation-Induced; Sarcoma, Experimental

1991
Cytotoxicity of lonidamine alone and in combination with other drugs against murine RIF-1 and human HT1080 cells in vitro.
    Cancer research, 1990, Dec-15, Volume: 50, Issue:24

    Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cisplatin; Drug Interactions; Drug Screening Assays, Antitumor; Fibrosarcoma; Humans; Indazoles; Kinetics; Mice; Neoplasms, Radiation-Induced

1990